Cargando…
Exosomal miR-34b inhibits proliferation and the epithelial-mesenchymal transition by targeting Notch2 in ovarian cancer
Exosomal microRNA (miR) can affect signaling pathways in various physiological and pathological conditions, including ovarian cancer (OC). miR-34b, the first microRNA targeted in a human clinical trial for cancer treatment, exhibited decreased expression in several cancer types. However, the biologi...
Autores principales: | Lu, Shenglian, Liu, Wuxia, Shi, Hong, Zhou, Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400462/ https://www.ncbi.nlm.nih.gov/pubmed/32782588 http://dx.doi.org/10.3892/ol.2020.11837 |
Ejemplares similares
-
miR-34a inhibits pancreatic cancer progression through Snail1-mediated epithelial–mesenchymal transition and the Notch signaling pathway
por: Tang, Yan, et al.
Publicado: (2017) -
miR-34c attenuates epithelial-mesenchymal transition and kidney fibrosis with ureteral obstruction
por: Morizane, Ryuji, et al.
Publicado: (2014) -
Exosomes in ovarian cancer ascites promote epithelial–mesenchymal transition of ovarian cancer cells by delivery of miR-6780b-5p
por: Cai, Jing, et al.
Publicado: (2021) -
miR-155 promotes proliferation and epithelial-mesenchymal transition of MCF-7 cells
por: Liu, Xiaoyan, et al.
Publicado: (2021) -
miR-30c plays diagnostic and prognostic roles and mediates epithelial–mesenchymal transition (EMT) and proliferation of gliomas by affecting Notch1
por: Li, Mengkao, et al.
Publicado: (2022)